Edesa Biotech Inc./$EDSA
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.
Ticker
$EDSA
Sector
Trading on
Industry
Biotechnology
Headquarters
Markham, Canada
Employees
16
ISIN
CA27966L3065
Website
EDSA Metrics
BasicAdvanced
$14M
-
-$1.55
0.38
-
Price and volume
Market cap
$14M
Beta
0.38
52-week high
$2.60
52-week low
$1.83
Average daily volume
29K
Financial strength
Current ratio
15.729
Quick ratio
15.193
Management effectiveness
Return on assets (TTM)
-35.30%
Return on equity (TTM)
-58.78%
Valuation
Price to book
0.88
Price to tangible book (TTM)
0.88
Price to free cash flow (TTM)
-1.289
Growth
Earnings per share change (TTM)
-34.47%
3-year earnings per share growth (CAGR)
-44.53%
EDSA News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Edesa Biotech Inc. stock?
Edesa Biotech Inc. (EDSA) has a market cap of $14M as of June 13, 2025.
What is the P/E ratio for Edesa Biotech Inc. stock?
The price to earnings (P/E) ratio for Edesa Biotech Inc. (EDSA) stock is 0 as of June 13, 2025.
Does Edesa Biotech Inc. stock pay dividends?
No, Edesa Biotech Inc. (EDSA) stock does not pay dividends to its shareholders as of June 13, 2025.
When is the next Edesa Biotech Inc. dividend payment date?
Edesa Biotech Inc. (EDSA) stock does not pay dividends to its shareholders.
What is the beta indicator for Edesa Biotech Inc.?
Edesa Biotech Inc. (EDSA) has a beta rating of 0.38. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.